Twist Bioscience (TWST)
(Delayed Data from NSDQ)
$31.54 USD
+0.46 (1.48%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $31.53 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Twist Bioscience Corporation falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -204.62 | -217.86 | -152.10 | -139.93 | -107.67 |
Depreciation/Amortization & Depletion | 29.31 | 16.52 | 9.83 | 6.86 | 6.39 |
Net Change from Assets/Liabilities | -1.01 | -5.36 | -9.38 | -25.18 | 3.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 33.84 | 82.32 | 39.40 | 15.99 | 10.34 |
Net Cash From Operating Activities | -142.47 | -124.39 | -112.24 | -142.26 | -87.94 |
Property & Equipment | -27.78 | -101.86 | -27.06 | -9.87 | -14.74 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -13.92 | -0.48 | 0.00 | 0.00 |
Investments | 78.39 | -117.16 | 183.70 | -104.78 | -90.07 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 50.61 | -232.93 | 156.16 | -114.65 | -104.81 |
Uses of Funds
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.91 | 272.09 | 332.52 | 307.07 | 161.08 |
Issuance (Repayment) of Debt | 0.00 | -1.56 | -3.33 | -3.33 | -2.50 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.91 | 270.53 | 329.18 | 303.73 | 158.58 |
Effect of Exchange Rate Changes | -0.03 | -0.32 | 0.02 | 0.02 | 0.03 |
Net Change In Cash & Equivalents | -90.98 | -87.10 | 373.11 | 46.85 | -34.14 |
Cash at Beginning of Period | 380.26 | 467.36 | 94.25 | 47.40 | 81.54 |
Cash at End of Period | 289.28 | 380.26 | 467.36 | 94.25 | 47.40 |
Diluted Net EPS | -3.60 | -4.04 | -3.15 | -3.57 | -3.92 |
Fiscal Year End for Twist Bioscience Corporation falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -43.01 | -204.62 | -158.38 | -100.98 |
Depreciation/Amortization & Depletion | NA | 8.17 | 29.31 | 20.81 | 12.32 |
Net Change from Assets/Liabilities | NA | 0.53 | -1.01 | -1.45 | -13.47 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 11.33 | 33.84 | 17.25 | 3.77 |
Net Cash From Operating Activities | NA | -22.97 | -142.47 | -121.77 | -98.36 |
Property & Equipment | NA | -1.51 | -27.78 | -25.39 | -20.88 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 5.67 | 78.39 | 78.25 | 55.07 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 4.17 | 50.61 | 52.86 | 34.19 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -1.47 | 0.91 | 0.47 | 1.13 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -1.47 | 0.91 | 0.47 | 1.13 |
Effect of Exchange Rate Changes | NA | 0.12 | -0.03 | 0.02 | 0.34 |
Net Change In Cash & Equivalents | NA | -20.17 | -90.98 | -68.42 | -62.70 |
Cash at Beginning of Period | NA | 289.28 | 380.26 | 380.26 | 380.26 |
Cash at End of Period | NA | 269.12 | 289.28 | 311.84 | 317.56 |
Diluted Net EPS | NA | -0.75 | -0.81 | -1.01 | -1.04 |